Safety and Activity of PolyPEPI1018 Combined with Maintenance Therapy in Metastatic Colorectal Cancer: an Open-Label, Multicenter, Phase Ib Study

PURPOSE: Although chemotherapy is standard of care for metastatic colorectal cancer (mCRC), immunotherapy has no role in microsatellite stable (MSS) mCRC, a “cold” tumor. PolyPEPI1018 is an off-the-shelf, multi-peptide vaccine derived from 7 tumor-associated antigens (TAA) frequently expressed in mC...

ver descrição completa

Detalhes bibliográficos
Autores principales: Hubbard, Joleen M., Tőke, Enikő R., Moretto, Roberto, Graham, Rondell P., Youssoufian, Hagop, Lőrincz, Orsolya, Molnár, Levente, Csiszovszki, Zsolt, Mitchell, Jessica L., Wessling, Jaclynn, Tóth, József, Cremolini, Chiara
Formato: Online Artigo Texto
Idioma:English
Publicado em: American Association for Cancer Research 2022
Assuntos:
Clinical Trials: Immunotherapy
Acesso em linha:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365360/
https://www.ncbi.nlm.nih.gov/pubmed/35472243
http://dx.doi.org/10.1158/1078-0432.CCR-22-0112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365360/
https://www.ncbi.nlm.nih.gov/pubmed/35472243
http://dx.doi.org/10.1158/1078-0432.CCR-22-0112

Registos relacionados